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Abstract: A systematic review was conducted to answer the following PICO question: “Can patients
diagnosed with oral lichen planus (OLP) be rehabilitated with dental implants as successfully as
patients without OLP?”. A systematic review of the literature was done following the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements to gather available
and current evidence of oral lichen planus and its relationship with dental implants. The synthesis of
results was performed using a Binary Random-Effects Model meta-analysis. Summary measures were
odds ratios (ORs), frequencies, and percentages comparing the survival rate of dental implants placed
in patients with OLP vs. those in patients without OLP. The electronic search yielded 25 articles, after
removing the duplicated ones, 24 articles were selected. Out of the 24 articles, only 15 fulfilled the
inclusion criteria. According to the results of the meta-analysis, with a total sample of 48 patients
with OLP and 49 patients without OLP, an odds ratio of 2.48 (95% CI 0.34–18.1) was established, with
an I2 value of 0%. According to the Strength of Recommendation Taxonomy (SORT) criteria, level A
can be established to conclude that patients with OLP can be rehabilitated with dental implants.
Keywords: oral lichen planus; dental implants; survival rate
1. Introduction
Oral lichen planus (OLP) is an autoimmune and chronic inflammatory disease [1–3]. The
etiology of OLP is still unknown, but it is believed to be associated with a cell-mediated immune
dysregulation [4].
The prevalence of this inflammatory disease involves 1–2% of the population, the epidemiology
od OLP was evaluated in 1987 by Axell and Rundquist [5], on this occasion it was concluded that 16%
of the cases were among men and 22% among women. The highest prevalence was found in patients
between the age of 55 and 74 years.
Therefore, OLP usually appears in women and in the age group of 50 to 70 years old.
The meta-analysis carried out by Aghbari et al. [2] concluded that 1.1% of patients with OLP
developed oral squamous cell carcinoma (OSCC).
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Since OLP is a mucosal disease, it has been suggested to affect the ability of attachment to the
titanium surface; and although some conditions are considered as risk factors for dental implants,
there are only a few absolute contraindications for this rehabilitation option [1].
Taking this statement into account, oral rehabilitation with dental implants in patients with OLP
needs to be questioned; in fact, surgical injury due to the implant insertion procedure should be
avoided during active, erosive phases of OLP. Frequent follow-ups are needed in order to rule out
inflammatory tissue response interfering with long-term survival of implants [1].
Excellent results in patients without general pathologies have been reported with survival and
success rates of implant, in a long-term follow-up [6]. Furthermore, oral rehabilitation with dental
implants has a 92–95% success rate in patients without any oral or systemic condition [7].
However, other factors such as smoking and the level of oral hygiene can affect osseointegration
and lower dental implant success rates [8].
The main aim when treating patients with OLP is to avoid irritating factors for the mucosa, since
this disease may appear in either asymptomatic or symptomatic forms. Patients may refer to burning
or occasional pain [1–4].
This systematic review was conducted to answer the following PICO question: “Can patients
diagnosed with OLP be rehabilitated with dental implants with the same survival rate as patients
without OLP?”.
2. Experimental Section
A systematic review of the literature was done following the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statements [9] to gather available and current
evidence of oral lichen planus and its relationship with dental implants (Figure 1). The review was
carried out from February 2020 to April 2020. Electronic research without restriction dates was
carried out using two different electronic databases: PubMed and the Cochrane Central Register for
Controlled Trials.
The following terms were searched in PubMed and Cochrane; (“Lichen Planus, Oral” [Mesh])
AND “Dental Implants” [Mesh].
Inclusion criteria were articles written in English or Spanish, meta-analyses, systematic reviews,
randomized-control trials, cohort studies, and case reports.
On the other hand, exclusion criteria were animal studies, in vitro studies, and descriptive reviews.
The primary outcome of this article was to establish whether patients with OLP had the same
survival rate as patients without OLP. Furthermore, secondary outcomes such as the protocol and
recommendations for patients with OLP who were rehabilitated with dental implants were reviewed.
The following data were extracted from the included studies (when available) by two independent
reviewer authors (A.T.-M. and C.S.-H.): authors, year, study design, number of subjects, gender,
age, OLP type, OLP location, OLP duration (in years), previous biopsy, number of implants, type
of prostheses, survival rate, follow-up (in months), malignant transformation, and OLP treatment.
Discrepancies were resolved with the other authors (K.I.-G., A.M.R., and A.E.-D.), and finally data
were validated by J.L.L.
The selected studies were assessed following the Strength of Recommendation Taxonomy (SORT)
criteria [10].
A quality assessment of the publications included for the systematic review was not applicable
due to the entity of included publications. Blinding of participants and personnel (performance bias)
and blinding of outcome assessment (detection bias) were not applicable, since most publications were
case reports. Due to selective reporting within case reports, attrition bias (incomplete outcome data)
and reporting bias (selective reporting) were assumed to be high.
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
Statistical Analysis
The synthesis of results was performed using a Binary Random-Effects Model meta-analysis.
Summary measures were odds ratios (ORs), frequencies, and percentages comparing the survival rate
of dental implants placed in patients with OLP vs. those in patients without OLP.
Forest plots were produced to graphically represent the odds ratio of successful placement of the
dental implant in patients with OLP and among patients without OLP (Figure 2).
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3. Results
The electronic search, in PubMed and Cochrane databases, yielded 25 articles, after removing the
duplicated ones, 24 articles were selected. Out of the 24 articles, only 15 fulfilled the inclusion criteria.
As shown in Table 1, all articles [11–24] were level 2, according to the SORT criteria [10], except
for a retrospective study [15] and a prospective controlled trial [25] that were level 1. Most of the
articles [11–19,21,24] were case reports, there were three retrospective studies [15,20,23] and two
prospective studies [22,25].
A total of 110 patients were examined, with an age range of 51 to 81 years old. There were a total
of 83 female patients (75.45%) and 27 male patients (24.55%). Not all the studies evaluated the type of
OLP, although a total of 72 patients were divided by the type of OLP. The most common OLP type was
erosive OLP (42 cases—58.33%), followed by the reticular OLP (22 cases—30.55%) and the atrophic
type (8 cases—11.11%). Regarding the location of OLP, a total of 29 locations were mentioned; the most
common location was the buccal mucosa (22 cases—75.86%), following the gingiva (5 cases—17.24%),
the tongue (1 case—3.44%), and the palate (1 case—3.44%).
From the 15 articles selected, only 8 [12,16,17,19,20,23–25] mentioned realizing a biopsy to diagnose
OLP, and the survival rate was only mentioned in 9 articles [12–14,17,18,20–23,25], the mean of the
survival rate was 93.88%.
Regarding the type of prostheses, it was analyzed in most of the articles, and a total of 113 prostheses
were analyzed, the most used type of protheses was the fixed partial (95 rehabilitations—84.07%), the
second most used was the fixed complete rehabilitation (10 rehabilitations–8.84%), and the overdenture
(8 rehabilitations–7.07%).
Concerning OLP treatment when patients were being rehabilitated with dental implants, it was
only considered in 6 articles [17,20,22–25]. All of them used oral corticosteroids with different active
ingredients and different posology. The most used oral corticosteroid was triamcinolone acetonide 0.01
3 times/day [20,24], except for Hernández et al. [25], who used prednisone 30 mg 1 time/day for 5 to
10 days in 2 patients, and Anitua et al. [23], who used deflazacort 20 mg 2 days preoperative and 15
mg postoperative during 3 days and 7.5 mg during 3 days. Czerninski et al. [17] used dexamethasone
0.4%, triamcinolone 8 mg, or clobetasol propionate ointment 0.05% applied once or twice daily for
not more than 2 weeks as an initial treatment, but during the follow-up, they changed to less-potent
steroids. Furthermore, Aboushelib and Elsafi [22] used a diode laser as an alternative therapy.
Regarding malignant transformation, 5 articles stated a malignant transformation [15,16,18–20].
A total of 8 patients (7.3%) were diagnosed with a malignant pathology after placing the implants.
Of these, 2 patients (25%) had risk factors such as alcohol consumption and smoking habits, 4 patients
(50%) did not have any kind of risk factor, and in the case of the 2 remaining (25%) patients it was
not reported.
Regarding the 8 patients who were diagnosed with oral squamous cell carcinoma, only 4 of
them [16,19] had a previous biopsy confirming the oral lichen planus; therefore, only 50% of the
patients presented malignant transformation had a previous histopathological confirmation of oral
lichen planus.
Moreover, 3 patients (37.5%) reported a previous malignant pathology, 3 patients (37.5%) reported
not having any history of OSCC, and for the 2 remaining patients (25%) it was not reported.
According to the results of the meta-analysis, with a total sample of 48 patients with OLP and
49 patients without OLP, an odds ratio of 2.48 (95% CI 0.34–18.1) was established. Indicating that
patients with OLP had a 2.48 times higher survival with dental implants in comparison with patients
without OLP, and the I2 was used to assess heterogeneity between studies.
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4. Discussion
Based on our systematic review of the literature and answering our PICO question: rehabilitation
with dental implants in patients with OLP is a valid treatment option with a survival rate of 93.88%.
This survival rate is similar to the survival rate of implant rehabilitation in patients without any
pathology or systemic condition, which is 92% or 95%, depending on the prosthetic rehabilitation [7].
In order to maintain this high survival rate, frequent follow-up appointments and oral hygiene
instructions should be established to eliminate inflammatory tissue response (peri-implant mucositis
and peri-implantitis) [1].
Although the most common type of OLP is the reticular type [26], followed by the erosive type,
in this review, the most common type was the erosive OLP, this could be explained because not all
studies reported which type of OLP was diagnosed or because some professionals ignore or do not
think the reticular type is relevant. The buccal mucosa was the most common location for OLP in
agreement with other articles [27,28].
We would like to point out, that we were surprised by the fact that none of the articles mentioned
previously reported any case of re-activation of OLP or an atrophic or erosive stage after the placement
of dental implants.
Furthermore, although the malignant transformation rate calculated (7.3%) is substantially higher
than the one reported by Aghbari et al. [2] in patients with OLP, 50% of the registered cases were not
confirmed with a previous biopsy, therefore we cannot confirm that they were OLP cases. As well, we
should consider that these results are not extendable to a general population since the patient sample
reported is very small.
Additionally, we were surprised by the fact, that not all the studies that reported malignant
transformation, reported the time that elapsed between the OLP diagnoses and the development of
OSCC, and again, the frequency with which the patients were evaluated was not mentioned.
Another notable matter is the fact that only 53.33% of the studies analyzed related performing a
biopsy to diagnose the OLP. However, both clinical and histopathologic criteria need to be present to
diagnose OLP, according to the modified WHO diagnostic criteria of OLP and oral lichenoid lesions,
proposed by van der Meij and van der Waal [29]. Therefore, we consider that it is difficult to know if
the other 46.67% were correctly diagnosed since there was no reference to histopathologic evaluation.
Regarding the meta-analysis, an odds ratio of 2.48 was established, indicating that patients with
OLP have a higher survival rate in comparison with patients without OLP. However, these results are
based on only 2 studies [20,25], since they were the only studies with patients with OLP and a control
group in the literature. These results may be explained since patients with OLP have more frequent
controls and a more meticulous oral hygiene control, therefore any alteration could be detected earlier.
These results should be evaluated with caution since there are only two studies and with small sample
sizes. We recommend new studies with larger sample size and longer follow-up.
According to our results, implant rehabilitation in patients with OLP is not contraindicated, and
survival rates are comparable to those of patients without OLP.
Given the foregoing [30], our workgroup would like to propose a protocol for OLP treatment and
monitoring when rehabilitated with dental implants (Figure 3).
(i) Initially, we would like to remark on the importance of a detailed medical history, a photographic
register, and a biopsy to confirm the OLP diagnosis.
(ii) Secondly, and in agreement with Hernández et al. [25], no implants should be placed until the
remission of atrophic or erosive forms is achieved, in other words, no patients should be treated during
a flare-up period of the disease. Erosive and atrophic OLP is mostly symptomatic and pain can be one
of the main characteristics. Therefore, if we are to rehabilitate a patient with symptomatic OLP, we
agree with Aboushelib and Elsafi [22] and Anitua et al. [23] and propose a prophylactic corticosteroid
therapy, to avoid the reactivation of erosive and atrophic OLP after the implant surgery. Again, other
authors, such as Hernández et al. [25] also reported using systemic corticosteroids to manage acute
phases of OLP.
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The guideline that we propose is deflazacort 30 mg 2 days pre-operative, 15 mg 3 days
post-operative, and 7.5 mg for 3 more days. We propose deflazacort since it is a synthetic glucocorticoid
characterized by high efficacy and good tolerability, widely used in autoimmune disease and
dermatology [31].
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5. Conclusions
According to the SORT criteria [9], level A can be established to conclude that patients with OLP
can be rehabilitated with dental implants.
More studies with longer follow-up and higher levels of evidence, such as randomized-controlled
trials, are needed.
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